The Glucocorticoid Toxicity Index (GTI) is intended to be a comprehensive instrument for assessing the toxicity associated with glucocorticoids. It was developed at multiple institutions in North America and Europe.
Parameters:
(1) body mass index (BMI)
(2) glucose tolerance
(3) blood pressure
(4) lipids
(5) bone density
(6) steroid myopathy
(7) skin toxicity
(8) neuropsychiatric toxicity
(9) infection
Parameter |
Finding |
Points |
body mass index |
improvement (weight loss) |
-8 |
|
no change |
0 |
|
moderate increase |
21 |
|
major increase |
36 |
glucose tolerance |
improvement |
-8 |
|
no change |
0 |
|
worsening |
32 |
|
worsening despite therapy |
44 |
blood pressure |
improvement |
-10 |
|
no change |
0 |
|
worsening |
19 |
|
worsening despite therapy |
44 |
lipids |
improvement |
-9 |
|
no change |
0 |
|
worsening |
10 |
|
worsening despite therapy |
30 |
bone density |
improvement |
-1 |
|
no change |
0 |
|
decrease |
29 |
steroid myopathy |
none |
0 |
|
mild |
9 |
|
moderate or severe |
63 |
skin toxicity |
none |
0 |
|
mild |
8 |
|
moderate or severe |
16 |
neuropsychiatric toxicity |
none |
0 |
|
mild |
11 |
|
moderate or severe |
74 |
infection |
none significant |
0 |
|
mucosal candidiasis or uncomplicated zoster |
19 |
|
Grade III infection or greater |
93 |
total score =
= SUM(points for all 9 parameters)
Interpretation:
• minimum score: -36
• maximum score: 429 (439 in document)
• The higher the score the worse the impact of glucocorticoid therapy.
Specialty: Endocrinology, Pharmacology, clinical